Lung cancer is the most common cause of death with malignant tumor in China. The whole-process management mode of lung nodules and lung cancer was established, and lung nodules were included in the standardized diagnosis and treatment system, aim to improve the rate of early diagnosis and treatment for lung cancer, compliance of patients with following up.

A cloud platform for the whole-process intelligent management of pulmonary nodules and lung cancer was constructed. Malignant pulmonary nodules, benign pulmonary nodules and undiagnosed pulmonary nodules queues were established. Demographic, imaging, pathological, curative effect and other information were collected, and population characteristics, diagnosis and treatment accuracy and return visit rate were analyzed after the whole process of management.

A cloud platform for whole-process intelligent management of pulmonary nodules and lung cancer was established based on Chongqing Pulmonary Nodules Management Studio. From January 2019 to December 2021, a total of 5 144 patients with pulmonary nodules and lung cancer were included in the whole-course management. 1 546 patients (30.05%) were confirmed including 1 194 malignant cases and 352 benign cases. Lung cancer with Stage Ia was accounted for 80.80%. 3 598 patients(69.95%)with lung nodules in follow up. Among undiagnosed pulmonary nodules after entering the platform registration management in 2019, the proportion of patients with ≥1 following-up was 74.86%. 667 patients (65.67%) in 2020. 245 patients (13.94%) in 2021.

The establishment of the cloud platform for the whole-process intelligent management of pulmonary nodules and lung cancer is beneficial to improve the rate of early diagnosis and treatment of malignant pulmonary nodules and patient compliance, promote the development of self-health management mode of patients and the prognosis of lung cancer, which is worthy of further promotion.